Effect of LCZ696 on Urinary Microalbumin and Pulse Wave Velocity in Perimenopausal Patients With Hypertension
Status:
Recruiting
Trial end date:
2021-07-09
Target enrollment:
Participant gender:
Summary
To explore the efficacy of Sacubitril/Valsartan in the treatment of perimenopausal
hypertensive patients, as well as the difference between the antihypertensive efficacy and
valsartan, the therapeutic effect of its exposure to different factors and the protection of
target organs.To provide reference for the clinical treatment of perimenopausal hypertension
patients with shakubactrivalsartan.
1. To evaluate the effects of Sacubitril/Valsartan on urinary microalbumin and pulse wave
velocity in perimenopausal hypertension patients.
2. To evaluate the clinical application of Sacubitril/Valsartan in the treatment of
perimenopausal hypertension, so as to improve the blood pressure management ability and
control rate of patients with such hypertension.